{"id":341728,"date":"2026-11-06T12:01:03","date_gmt":"2026-11-06T06:31:03","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/"},"modified":"2026-11-06T12:01:03","modified_gmt":"2026-11-06T06:31:03","slug":"abbott-india-q2-results-fy27-pat-453-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/","title":{"rendered":"Abbott India Q2 Results FY27: Revenue Rises 11.03% to Rs 1,951.01 Cr, PAT Rs 453.45 Cr"},"content":{"rendered":"<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Abbott India Q2 Results FY27 were declared on 5 November 2026, with revenue of Rs 1,951.01 Cr against Rs 1,757.15 Cr a year earlier, which is YoY growth of 11.03%. Net profit came in at Rs 453.45 Cr compared with Rs 415.27 Cr, up 9.19%. These quarterly results cover the July to September 2026 quarter.<\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/stocks\/abbotindi\/abbott-india-ltd-share-price-today\">Abbott India Ltd<\/a> (ABBOTINDIA) Q2 Results FY27 announced on 5 November 2026, covering the company&#8217;s financial performance for the July to September quarter. The results date brought revenue of Rs 1,951.01 Cr and PAT of Rs 453.45 Cr, and Abbott India Q2 Results FY27 record a rise in both lines against the same quarter last year.<\/p>\n<p>This Abbott India Q2 Results report gives a full results analysis of the quarter. It covers the financial highlights, the business factors visible in the numbers, the FY27 outlook and the key risks, and Univest readers can begin with the Financial Highlights table that follows.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly_results\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Abbott_India_Q2_Results_FY27_Financial_Highlights\" title=\"Abbott India Q2 Results FY27: Financial Highlights\">Abbott India Q2 Results FY27: Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Key_Takeaways_from_Abbott_India_Q2_Results_What_Stands_Out\" title=\"Key Takeaways from Abbott India Q2 Results: What Stands Out\">Key Takeaways from Abbott India Q2 Results: What Stands Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Abbott_India_Q2_Results_FY27_Performance_Analysis\" title=\"Abbott India Q2 Results FY27: Performance Analysis\">Abbott India Q2 Results FY27: Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Key_Business_Factors_This_Quarter\" title=\"Key Business Factors This Quarter\">Key Business Factors This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#FY27_Outlook_After_Abbott_India_Q2_Results\" title=\"FY27 Outlook After Abbott India Q2 Results\">FY27 Outlook After Abbott India Q2 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Key_Risks_to_Watch_After_Abbott_India_Q2_Results_FY27\" title=\"Key Risks to Watch After Abbott India Q2 Results FY27\">Key Risks to Watch After Abbott India Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Lower_Return_on_Equity\" title=\"Lower Return on Equity\">Lower Return on Equity<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Lower_Return_on_Capital_Employed\" title=\"Lower Return on Capital Employed\">Lower Return on Capital Employed<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Frequently_Asked_Questions_on_Abbott_India_Q2_Results_FY27\" title=\"Frequently Asked Questions on Abbott India Q2 Results FY27\">Frequently Asked Questions on Abbott India Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#What_are_Abbott_India_Q2_Results_FY27\" title=\"What are Abbott India Q2 Results FY27?\">What are Abbott India Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#What_is_the_results_date_for_Abbott_India_Q2_Results_FY27\" title=\"What is the results date for Abbott India Q2 Results FY27?\">What is the results date for Abbott India Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#What_revenue_was_reported_in_Abbott_India_Q2_Results_FY27\" title=\"What revenue was reported in Abbott India Q2 Results FY27?\">What revenue was reported in Abbott India Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#What_net_profit_was_reported_in_Abbott_India_Q2_Results_FY27\" title=\"What net profit was reported in Abbott India Q2 Results FY27?\">What net profit was reported in Abbott India Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#How_much_YoY_growth_did_revenue_show_in_Abbott_India_Q2_Results_FY27\" title=\"How much YoY growth did revenue show in Abbott India Q2 Results FY27?\">How much YoY growth did revenue show in Abbott India Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Did_net_profit_rise_or_fall_in_Abbott_India_Q2_Results\" title=\"Did net profit rise or fall in Abbott India Q2 Results?\">Did net profit rise or fall in Abbott India Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#How_much_did_net_profit_add_in_Abbott_India_Q2_Results_FY27\" title=\"How much did net profit add in Abbott India Q2 Results FY27?\">How much did net profit add in Abbott India Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#What_return_ratios_are_noted_after_Abbott_India_Q2_Results\" title=\"What return ratios are noted after Abbott India Q2 Results?\">What return ratios are noted after Abbott India Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#What_business_factors_shaped_Abbott_India_Q2_Results_FY27\" title=\"What business factors shaped Abbott India Q2 Results FY27?\">What business factors shaped Abbott India Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#What_are_the_key_risks_after_Abbott_India_Q2_Results_FY27\" title=\"What are the key risks after Abbott India Q2 Results FY27?\">What are the key risks after Abbott India Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#What_is_the_outlook_after_Abbott_India_Q2_Results\" title=\"What is the outlook after Abbott India Q2 Results?\">What is the outlook after Abbott India Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-q2-results-fy27-pat-453-crore\/#Where_can_I_find_the_complete_Abbott_India_Q2_Results_FY27_data\" title=\"Where can I find the complete Abbott India Q2 Results FY27 data?\">Where can I find the complete Abbott India Q2 Results FY27 data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Abbott_India_Q2_Results_FY27_Financial_Highlights\"><\/span><strong>Abbott India Q2 Results FY27: Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q2 FY27 (Sep 26)<\/th>\n<th>Q2 FY26 (Sep 25)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 1951.01 Cr<\/td>\n<td>Rs 1757.15 Cr<\/td>\n<td>+11.03% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs 453.45 Cr<\/td>\n<td>Rs 415.27 Cr<\/td>\n<td>+9.19% YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source: company filing for Abbott India Q2 Results FY27, 5 November 2026. Figures in Rs Crore.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_Abbott_India_Q2_Results_What_Stands_Out\"><\/span><strong>Key Takeaways from Abbott India Q2 Results: What Stands Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Revenue of Rs 1,951.01 Cr<\/strong> was up 11.03% from Rs 1,757.15 Cr in the same quarter last year, an addition of Rs 193.86 Cr.<\/li>\n<li><strong>Net profit of Rs 453.45 Cr<\/strong> compared with Rs 415.27 Cr a year earlier, a rise of 9.19% on a YoY basis.<\/li>\n<li><strong>Revenue growth ran ahead of profit growth<\/strong>, as the 11.03% rise in revenue sat above the 9.19% YoY growth in net profit in Abbott India Q2 Results FY27.<\/li>\n<li><strong>Net profit added Rs 38.18 Cr<\/strong> over the year-ago quarter, which is the gain behind the 9.19% increase.<\/li>\n<li><strong>The performance analysis comes next<\/strong>, where revenue and net profit are read across the year.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Abbott_India_Q2_Results_FY27_Performance_Analysis\"><\/span><strong>Abbott India Q2 Results FY27: Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Abbott India Q2 Results FY27 show revenue of Rs 1,951.01 Cr and net profit of Rs 453.45 Cr. Revenue rose 11.03% YoY, while net profit rose 9.19% YoY. The results analysis therefore shows a quarter where the top line expanded slightly faster than the bottom line.<\/p>\n<p>Within Abbott India Q2 Results, revenue added Rs 193.86 Cr over the Rs 1,757.15 Cr booked a year earlier, while net profit added Rs 38.18 Cr over Rs 415.27 Cr. These quarterly results show YoY growth in both reported lines.<\/p>\n<p>Another view in Abbott India Q2 Results FY27 comes from the gap between revenue growth of 11.03% and net profit growth of 9.19%. The supplied figures confirm what changed but do not establish the specific cause, which is where the results analysis turns to the business factors.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live results data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_This_Quarter\"><\/span><strong>Key Business Factors This Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Revenue Growth<\/strong> &#8211; The results analysis begins with revenue, which grew 11.0% year on year to Rs 1,951.01 Cr in the latest quarter. This is the base on which Abbott India Q2 Results FY27 build the profit line reported for the quarter.<\/p>\n<p><strong>Net Profit Growth<\/strong> &#8211; Net profit rose 9.2% year on year to Rs 453.45 Cr. The quarterly results show this gain moving a little slower than the revenue growth reported for the same quarter.<\/p>\n<p><strong>Return Ratios<\/strong> &#8211; Return on equity was 34.67% in FY26 and return on capital employed was 46.72% in FY26. These full-year ratios sit alongside the quarterly gain and lead directly into the FY27 outlook.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_After_Abbott_India_Q2_Results\"><\/span><strong>FY27 Outlook After Abbott India Q2 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The FY27 outlook for Abbott India depends on the quarters still to be reported, because full-year numbers are built from each quarterly filing. This results analysis therefore treats Abbott India Q2 Results FY27 as one data point in the year, with revenue of Rs 1,951.01 Cr and net profit of Rs 453.45 Cr.<\/p>\n<p>Full-year FY27 results will depend on subsequent quarters and on conditions disclosed in later filings, and this article does not project any figure beyond what was reported. Investors tracking net profit can compare each new quarter with the Rs 453.45 Cr reported here, which brings the focus to the key risks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_Abbott_India_Q2_Results_FY27\"><\/span><strong>Key Risks to Watch After Abbott India Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Lower_Return_on_Equity\"><\/span><strong>Lower Return on Equity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on equity declined to 34.67% in FY26 from 35.98% in FY25. Abbott India Q2 Results FY27 show higher net profit, so the YoY growth in profit is worth tracking against this full-year ratio in later filings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Lower_Return_on_Capital_Employed\"><\/span><strong>Lower Return on Capital Employed<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on capital employed declined to 46.72% in FY26 from 47.87% in FY25. Investors can watch whether later filings move this ratio, since it reflects returns on the capital used in the business.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track quarterly results as they are declared.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Abbott India Q2 Results FY27 record revenue of Rs 1,951.01 Cr, up 11.03% YoY, with net profit of Rs 453.45 Cr, up 9.19%. These quarterly results show both reported lines above last year, and the results are best read alongside later filings. Anyone reading Abbott India Q2 Results on Univest should consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Abbott_India_Q2_Results_FY27\"><\/span><strong>Frequently Asked Questions on Abbott India Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_Abbott_India_Q2_Results_FY27\"><\/span><strong>What are Abbott India Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India Q2 Results FY27 are the quarterly results for July to September 2026, with revenue of Rs 1,951.01 Cr and net profit of Rs 453.45 Cr, while the Quick Answer box summarises them for readers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_results_date_for_Abbott_India_Q2_Results_FY27\"><\/span><strong>What is the results date for Abbott India Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The results date for Abbott India Q2 Results FY27 is 5 November 2026. Alongside this, the filing covers the July to September 2026 quarter, with the figures set out in the Financial Highlights table that the opening paragraphs introduce.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_revenue_was_reported_in_Abbott_India_Q2_Results_FY27\"><\/span><strong>What revenue was reported in Abbott India Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India reported revenue of Rs 1,951.01 Cr for the quarter. Compared with Rs 1,757.15 Cr a year earlier, this is an increase of Rs 193.86 Cr, as the Financial Highlights table shows.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_net_profit_was_reported_in_Abbott_India_Q2_Results_FY27\"><\/span><strong>What net profit was reported in Abbott India Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India reported net profit of Rs 453.45 Cr in Q2 FY27. This compares with Rs 415.27 Cr a year earlier, so net profit rose 9.19% YoY, as the Key Takeaways section notes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_YoY_growth_did_revenue_show_in_Abbott_India_Q2_Results_FY27\"><\/span><strong>How much YoY growth did revenue show in Abbott India Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue showed YoY growth of 11.03% in Abbott India Q2 Results FY27, rising from Rs 1,757.15 Cr to Rs 1,951.01 Cr. This is slightly above the 9.19% net profit growth, as the Performance Analysis explains.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_net_profit_rise_or_fall_in_Abbott_India_Q2_Results\"><\/span><strong>Did net profit rise or fall in Abbott India Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit rose in Abbott India Q2 Results, moving from Rs 415.27 Cr to Rs 453.45 Cr, a gain of 9.19% YoY. Alongside this, revenue rose 11.03% to Rs 1,951.01 Cr, as the Performance Analysis covers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_net_profit_add_in_Abbott_India_Q2_Results_FY27\"><\/span><strong>How much did net profit add in Abbott India Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit added Rs 38.18 Cr in Abbott India Q2 Results FY27, moving from Rs 415.27 Cr a year earlier to Rs 453.45 Cr. This is a YoY rise of 9.19%, as the Key Takeaways section explains.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_return_ratios_are_noted_after_Abbott_India_Q2_Results\"><\/span><strong>What return ratios are noted after Abbott India Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Return on equity was 34.67% in FY26 and return on capital employed was 46.72% in FY26. Both ratios are covered in the Key Business Factors section alongside the quarterly revenue and net profit growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_business_factors_shaped_Abbott_India_Q2_Results_FY27\"><\/span><strong>What business factors shaped Abbott India Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The reported factors are revenue growth of 11.0%, net profit growth of 9.2%, FY26 return on equity of 34.67% and FY26 return on capital employed of 46.72%, as the Key Business Factors section details.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_after_Abbott_India_Q2_Results_FY27\"><\/span><strong>What are the key risks after Abbott India Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The listed risks are return on equity declining to 34.67% in FY26 from 35.98% in FY25, and return on capital employed declining to 46.72% from 47.87%. The Key Risks section explains each one.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_Abbott_India_Q2_Results\"><\/span><strong>What is the outlook after Abbott India Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Full-year FY27 results will depend on subsequent quarters and on conditions disclosed in later filings. Alongside this, the FY27 Outlook section treats the Rs 1,951.01 Cr revenue and Rs 453.45 Cr net profit as one data point.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_complete_Abbott_India_Q2_Results_FY27_data\"><\/span><strong>Where can I find the complete Abbott India Q2 Results FY27 data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The complete Abbott India Q2 Results FY27 data sits in the Financial Highlights table of this article, which lists revenue and net profit with YoY change, while Univest Screener lets readers track the company&#8217;s later filings.<\/p>\n<p><script type=\"application\/ld+json\" class=\"faq-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are Abbott India Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Abbott India Q2 Results FY27 are the quarterly results for July to September 2026, with revenue of Rs 1,951.01 Cr and net profit of Rs 453.45 Cr, while the Quick Answer box summarises them for readers.\"}},{\"@type\":\"Question\",\"name\":\"What is the results date for Abbott India Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The results date for Abbott India Q2 Results FY27 is 5 November 2026. Alongside this, the filing covers the July to September 2026 quarter, with the figures set out in the Financial Highlights table that the opening paragraphs introduce.\"}},{\"@type\":\"Question\",\"name\":\"What revenue was reported in Abbott India Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Abbott India reported revenue of Rs 1,951.01 Cr for the quarter. Compared with Rs 1,757.15 Cr a year earlier, this is an increase of Rs 193.86 Cr, as the Financial Highlights table shows.\"}},{\"@type\":\"Question\",\"name\":\"What net profit was reported in Abbott India Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Abbott India reported net profit of Rs 453.45 Cr in Q2 FY27. This compares with Rs 415.27 Cr a year earlier, so net profit rose 9.19% YoY, as the Key Takeaways section notes.\"}},{\"@type\":\"Question\",\"name\":\"How much YoY growth did revenue show in Abbott India Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue showed YoY growth of 11.03% in Abbott India Q2 Results FY27, rising from Rs 1,757.15 Cr to Rs 1,951.01 Cr. This is slightly above the 9.19% net profit growth, as the Performance Analysis explains.\"}},{\"@type\":\"Question\",\"name\":\"Did net profit rise or fall in Abbott India Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit rose in Abbott India Q2 Results, moving from Rs 415.27 Cr to Rs 453.45 Cr, a gain of 9.19% YoY. Alongside this, revenue rose 11.03% to Rs 1,951.01 Cr, as the Performance Analysis covers.\"}},{\"@type\":\"Question\",\"name\":\"How much did net profit add in Abbott India Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit added Rs 38.18 Cr in Abbott India Q2 Results FY27, moving from Rs 415.27 Cr a year earlier to Rs 453.45 Cr. This is a YoY rise of 9.19%, as the Key Takeaways section explains.\"}},{\"@type\":\"Question\",\"name\":\"What return ratios are noted after Abbott India Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Return on equity was 34.67% in FY26 and return on capital employed was 46.72% in FY26. Both ratios are covered in the Key Business Factors section alongside the quarterly revenue and net profit growth.\"}},{\"@type\":\"Question\",\"name\":\"What business factors shaped Abbott India Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The reported factors are revenue growth of 11.0%, net profit growth of 9.2%, FY26 return on equity of 34.67% and FY26 return on capital employed of 46.72%, as the Key Business Factors section details.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks after Abbott India Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The listed risks are return on equity declining to 34.67% in FY26 from 35.98% in FY25, and return on capital employed declining to 46.72% from 47.87%. The Key Risks section explains each one.\"}},{\"@type\":\"Question\",\"name\":\"What is the outlook after Abbott India Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Full-year FY27 results will depend on subsequent quarters and on conditions disclosed in later filings. Alongside this, the FY27 Outlook section treats the Rs 1,951.01 Cr revenue and Rs 453.45 Cr net profit as one data point.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the complete Abbott India Q2 Results FY27 data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The complete Abbott India Q2 Results FY27 data sits in the Financial Highlights table of this article, which lists revenue and net profit with YoY change, while Univest Screener lets readers track the company's later filings.\"}}]}<\/script><br \/>\n<script type=\"application\/ld+json\" class=\"news-article-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Abbott India Q2 Results FY27: Revenue Rises 11.03% to Rs 1,951.01 Cr, PAT Rs 453.45 Cr\",\"description\":\"Abbott India Q2 Results: Revenue \u20b91,951.01 Cr, PAT \u20b9453.45 Cr. Check YoY growth and quarterly results analysis from the 5 November 2026 filing.\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"Abbott India Ltd\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abbott India Q2 Results FY27: revenue Rs 1,951.01 Cr, up 11.03% YoY, with net profit at Rs 453.45 Cr, up 9.19%.<\/p>\n","protected":false},"author":29,"featured_media":341727,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-341728","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["341727"],"rank_math_title":["Abbott India Q2 Results FY27: Revenue Up 11.03%, PAT Rs 453.45 Cr"],"rank_math_description":["Abbott India Q2 Results: Revenue \u20b91,951.01 Cr, PAT \u20b9453.45 Cr. Check YoY growth and quarterly results analysis from the 5 November 2026 filing."],"rank_math_focus_keyword":["Abbott India Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/abbott-india-q2-results-fy27-revenue-rises-11-03-to-rs-1-951-01-cr-pat-rs-453-45.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/341728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=341728"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/341728\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/341727"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=341728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=341728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=341728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}